Benzinga | Oct 27, 2020 07:43AM EDT

NeoGenomics Q3 EPS $0.06 Beats $0.04 Estimate, Sales $125.44M Miss $126.23M Estimate

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 14.29 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $125.44 million which missed the analyst consensus estimate of $126.23 million by 0.62 percent. This is a 19.84 percent increase over sales of $104.67 million the same period last year.